Compare DSP Healthcare Fund vs SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
3.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.11
1.88
NAV
₹45.92
₹537.76
Fund Started
12 Nov 2018
04 Jun 1999
Fund Size
₹3142.36 Cr
₹4323.29 Cr
Exit Load
Exit load of 0.50% if redeemed within 1 month.
Exit load of 0.50% if redeemed within 15 days
1 Year
7.64%
10.30%
3 Year
21.83%
24.66%
5 Year
14.02%
15.39%
Equity
96.75%
97.38%
Cash
3.25%
2.55%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 8.84% |
Ipca Laboratories Ltd. | 8.26% |
Cipla Ltd. | 7.56% |
Globus Medical Inc | 7.35% |
Laurus Labs Ltd. | 6.42% |
Illumina Inc. (USA) | 6.16% |
Sai Life Sciences Ltd. | 6.10% |
Gland Pharma Ltd. | 5.13% |
Cohance Lifesciences Ltd. | 4.83% |
Apollo Hospitals Enterprise Ltd. | 4.73% |
Sun Pharmaceutical Industries Ltd. | 11.71% |
Divi's Laboratories Ltd. | 6.77% |
Acutaas Chemicals Ltd. | 5.40% |
Apollo Hospitals Enterprise Ltd. | 5.30% |
Max Healthcare Institute Ltd. | 5.17% |
Aster DM Healthcare Ltd. | 3.89% |
Lupin Ltd. | 3.84% |
Torrent Pharmaceuticals Ltd. | 3.48% |
Anthem Biosciences Ltd. | 3.45% |
Aether Industries Ltd. | 3.35% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
12 Nov 2018
04 Jun 1999
